A vaccine strategy with multiple prostatic acid phosphatase-fused cytokines for prostate cancer treatment

Immunotherapy is one of the attractive treatment strategies for advanced prostate cancer. The US Food and Drug Administration (FDA) previously approved the therapeutic vaccine, sipuleucel-T, which is composed of autologous antigen-presenting cells cultured with a fusion protein [prostatic acid phosp...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncol Rep
Autori principali: FUJIO, KEI, WATANABE, MASAMI, UEKI, HIDEO, LI, SHUN-AI, KINOSHITA, RIE, OCHIAI, KAZUHIKO, FUTAMI, JUNICHIRO, WATANABE, TOYOHIKO, NASU, YASUTOMO, KUMON, HIROMI
Natura: Artigo
Lingua:Inglês
Pubblicazione: D.A. Spandidos 2015
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4358080/
https://ncbi.nlm.nih.gov/pubmed/25632844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2015.3770
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi